HomeSearchGlobal LocationsContact UsGenzyme Websites
About GenzymeOur ResearchOur ProductsOur Commitment
Genzyme

Corporate Info
Investors
News
Investor Events
Financial Reports
Guidance and Reconciliation
Research Pipeline
Analyst Coverage
Corporate Governance
Frequently Asked Questions
News
Partnering
Genzyme Events
Careers
Global Locations

News

News Releases

News Subscription


Genzyme’s Most Recent News

inv_genz_news Genzyme General News
November 18, 2009 Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder
November 17, 2009 Data from Mipomersen Phase 3 Trial in hoFH Patients Presented at AHA
November 16, 2009 Genzyme Receives Complete Response Letter on Lumizyme Application
November 13, 2009 Genzyme Issues Letters to U.S. Healthcare Providers
October 21, 2009 Genzyme Reports Third-Quarter Financial Results
October 20, 2009 First Patient Enrolled in Phase 3 Trials of Genzyme Oral Capsule for Gaucher Disease
October 14, 2009 Scientists Name Genzyme a Top Employer
October 6, 2009 Genzyme Receives FDA Complete Response Letter for Clolar
October 2, 2009 Genzyme Named to Dow Jones Sustainability World and North American Indexes
September 24, 2009 Genzyme’s Campath Meets Primary Endpoint in Phase 3 Combination Therapy Trial for Chronic Lymphocytic Leukemia

Genzyme News—One Year Archive >
Genzyme Financial News >




Search News Releases

 

Financial News

Latest Earnings Report:

Q3 2009 Financial Results

Annual Report:

2008 Annual Report (HTML)
2007 Annual Report (HTML)


CONTACT INFORMATION:
Genzyme Investor Relations
500 Kendall Street
Cambridge, MA 02142
T: 617 252 7500


Patrick Flanigan – 617 768 6563


Investor Information Line

U.S. T: 800 905 4369
Outside the U.S. T: 678 999 4572

Shareholder Contact

For questions about your shares, replacement of a lost stock certificate or a change of address call our transfer agent.

American Stock Transfer

59 Maiden Lane
New York, NY 10038
T: 212 936 5100
or
Genzyme Shareholder Services
T: 617 768 6686

Terms and Conditions of Use | Privacy Policy | © 2002-2009 Genzyme Corporation. All rights reserved.